Myocardial Ischemia Market Research Reports 2019 | Global Industry Size, Share, Emerging Trends, Growth Boosted By Demand and Advanced Technology till 2023
The increasing cases
of coronary artery disease and diabetes coupled with growing obesity globally
are driving the market growth. On top of that, growing awareness related to
heart conditions, technological advancement in treatments, and rising numbers
of hospitals and healthcare infrastructure around the globe have propelled the
myocardial ischemia market expansion. Moreover, strong economic growth,
disposable incomes of patients, and improved standard of living can fuel the
market growth over the forecast period.
Global Market for
Myocardial Ischemia – Segmental Analysis
The global
myocardial ischemia market is segmented on the basis of type, diagnosis &
treatment, and end-user.
By type, the market
is segmented on the basis of symptomatic and asymptomatic. The asymptomatic
(silent) myocardial ischemia segment accounted for the largest market share in
2017. Growing number of smokers, family history of heart diseases, prevalence
of cases of high cholesterol and high blood pressure, and lack of exercise can
drive the growth in the segment.
By treatment &
diagnosis, the market is segmented into treatment and diagnosis. The diagnosis
segment is sub-segmented into imaging and stress test. On the other hand, the
treatment segment is sub-segmented into medications and surgery. The treatment
segment has gained significant traction owing to increasing prevalence of
coronary heart disease and large population leading a stressful lifestyle.
Thus, the treatment segment is estimated to hold largest market share till the
end of the forecast period.
Table of Content
5.1 Value Chain Analysis
5.1.1 R&D And Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.2 Bargaining Power Of Buyers
5.2.3 Threat Of New Entrants
5.2.4 Threat Of Substitutes
5.2.5 Intensity Of Rivalry
5.3 Investment Opportunities
5.4 Pricing Analysis
5.5 Demand & Supply: Gap
Analysis
Continued…
Get detailed information on Global Myocardial Ischemia
Market: Information by Type (Symptomatic and Asymptomatic), Treatment &
Diagnosis (Diagnosis and Treatment), End User (Hospitals & Clinics,
Diagnostic Centers and Ambulatory Surgery Centers) and Region (Americas,
Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2023@ https://www.marketresearchfuture.com/reports/myocardial-ischemia-market-5811
Growing trend in the myocardial ischemia market is
increasing usage of myocardial perfusion imaging. It is a stress test which
relies on imaging of a patient’s heart before and after physical activity to
determine the effects of stress on the flow of blood through the coronary
arteries and the heart muscle.
Top Key Players of the market
·
Taxus Cardium (US),
·
ViroMed Co. Ltd. (Republic of Korea ),
·
Edward Lifesciences (US),
·
Daiichi Sankyo Company Limited (Japan),
·
Boston Scientific Corporation (US),
·
Merck KGaA (Germany),
·
Novartis AG (Switzerland),
·
Boehringer Ingelheim International GmbH
(Germany),
·
Johnson & Johnson Services Inc. (US),
·
Bayer AG (Germany),
·
AstraZeneca (UK).
Browse Other Related healthcare report
Blood
Glucose Monitoring Market Research Report - Global Forecast till 2023
Surgical
Lights Market Research Report - Forecast to 2023
About
Market Research Future:
MRFR
team has supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by
Components, Application, Logistics and market players for global, regional, and
country-level market segments, enable our clients to see more, know more, and
do more, which help to answer all their most important questions.
In
order to stay updated with the technology and work process of the industry,
MRFR often plans & conducts meet with the industry experts and industrial
visits for its research analyst members.
Contact:
Comments
Post a Comment